People with migraines have differences in an area of the brain that helps process sensory information, including pain, according to a study published in the November 20, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.
The study found that part of the cortex area of the brain is thicker in people with migraine than in people who do not have the neurological disorder.
Comparing 24 people with migraine to 12 people without migraine, the study found that the somatosensory cortex area of the brain was an average of 21 percent thicker in those with migraine.
“Repeated migraine attacks may lead to, or be the result of, these structural changes in the brain,” said study author Nouchine Hadjikhani, MD, of The Martinos Center for Biomedical Imaging at Massachusetts General Hospital in Boston. “Most of these people had been suffering from migraines since childhood, so the long-term overstimulation of the sensory fields in the cortex could explain these changes. It’s also possible that people who develop migraines are naturally more sensitive to stimulation.”
Hadjikhani said the results indicate that the brain’s sensory mechanisms are important components in migraine. “This may explain why people with migraines often also have other pain disorders such as back pain, jaw pain, and other sensory problems such as allodynia, where the skin becomes so sensitive that even a gentle breeze can be painful.”
Other studies have shown changes in the cortex. The area becomes thinner in neurological disorders such as multiple sclerosis and Alzheimer’s disease. But the area thickens with extensive motor training and learning.
Source: American Academy of Neurology
Related stories:
Migraine linked to blood clots in veins
People with migraines may also be more likely to develop blood clots in their veins, according to a study published in the September 16, 2008, issue of
Neurology the medical journal of the American Academy of Neurology.
Oxygen therapy might ease pain of migraine, cluster headaches
Two types of oxygen therapy could offer some relief to adults who suffer from disabling migraine and cluster headaches, according to a new research review from Australia.
Combination drug taken early relieves migraine symptoms
A combination drug taken within an hour after the start of a migraine is effective in relieving symptoms, according to research published in the July 8, 2008, issue of
Neurology, the medical journal of the American Academy of Neurology.
Migraine mutations reveal clues to biological basis of disorder
Fifteen percent to 20 percent of people worldwide suffer from migraines – excruciating headaches often presaged by dramatic sensations, or "auras." By studying a rare, inherited form of migraine, researchers at Vanderbilt University Medical Center have found clues to the biological basis of the painful, debilitating disorder.
Portable device effective in zapping away migraine pain
novel electronic device designed to "zap" away migraine pain before it starts has proven to be the next form of relief for those suffering from the debilitating disease, according to a study conducted at The Ohio State University Medical Center.
Office initiative reduces headaches and neck and shoulder pain by more than 40 percent
Office staff who took part in an eight-month workplace initiative reported that headaches and neck and shoulder pain fell by more than 40 per cent and their use of painkillers halved, according to research published in the May issue of
Cephalalgia.
Migraine increases risk of severe skin sensitivity and pain
People with migraine are more likely to experience exacerbated skin sensitivity or pain after non-painful daily activities such as rubbing one’s head, combing one’s hair and wearing necklaces or earrings, compared to people with other types of headache, according to a study published in the April 22, 2008, issue of
Neurology, the medical journal of the American Academy of Neurology.
Concentrating on different aspects of pain leads to breakthrough in migraine genetics
Migraine is the most common cause of episodic headache, and by far the most common neurological cause of a doctor’s visit. It affects some 15% of the population, including some 41 million people in Europe, and places a considerable burden on healthcare in both the developed and the developing world.